3 hours Q4 EPS Forecast for Stoke Therapeutics Raised by AnalystMarketBeat
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Analysts at Leerink Partnrs boosted their Q4 2024 earnings per share estimates for shares of Stoke Therapeutics in a research report issued to clients and investors on Tuesday, October 15th. Lee…
Earnings · Nasdaq 100 · Science
X